ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

First Report and Mechanistic Analysis of Chronic GVHD after Solid Organ Transplantation

J. Weiner, N. Svetlicky, J. Schmidt, J. Kang, M. Sadat, A. Karaballa, S. Moturi, O. Aguirre, J. Hawksworth, C. Matsumoto, T. Fishbein, A. Kroemer

Georgetown University Hospital, Washington, DC

Meeting: 2019 American Transplant Congress

Abstract number: D344

Keywords: FACS analysis, Graft-versus-host-disease, Intestinal transplantation, T cells

Session Information

Date: Tuesday, June 4, 2019

Session Name: Poster Session D: Small Bowel: All Topics

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Central Role of Graft Resident Memory T Cells in Pathogenesis of GVHD after Bowel Transplantation
  • First Report and Mechanistic Analysis of Operational Tolerance after Intestinal Transplant

*Purpose: Chronic graft-versus-host disease (cGVHD) occurs late after bone marrow transplantation and is associated with a characteristic lichenoid rash (cutaneous sclerosis) and effects on multiple body systems. It has never been reported after solid organ transplantation. Resident memory T cells (TRM) are a newly described T cell subset with memory phenotype localizing to peripheral tissue rather than blood/lymphatics. We sought to characterize the immunologic response during this novel presentation.

*Methods: Intestinal transplantation from a deceased donor was performed using our standard surgical method. As with our other bowel recipients, graft and blood lymphocytes were longitudinally analyzed using flow cytometry. Thymoglobulin and steroids were used for immunosuppression induction and tacrolimus for maintenance. Chimerism was assessed by the Blood Center of Wisconsin.

*Results: A 20-year old male was transplanted for short gut syndrome and rejected his first graft, requiring retransplant after 4 years. He began to experience GVHD 3 months after re-transplant, including a persistent rash, and by 9 months exhibited cutaneous sclerosis, bronchiolitis obliterans, liver failure, eye damage, pancytopenia, and mucosal damage along the entire native alimentary tract. Versus those without GVHD, CD4 and CD8 TRM percentages at the time of diagnosis were significantly elevated in the graft (88.9% vs. 73% and 97% vs. 60.1%) but also blood (13.5% vs. 0.045% and 26% vs. 1.6%) and native bowel (overall 49.2% vs. 25%) with 93% donor lymphocyte chimerism. In longitudinal analysis, the percentage of CD4 effector memory cells in the blood at time of GVHD compared to the last normal time-point increased by 41.5% and CD8 effector memory cells by 52.7%. During the same time period, expression of CD4/PD-1 increased by 10.4%, CD8/PD-1 increased by 22%, CD4/HLA-DR increased by 46.5%, and CD8/HLA-DR increased by 72.7%, indicating the increased prevalence of T cells with antigen-experienced and activation/exhaustion phenotype.

*Conclusions: This is the first report of cGVHD after solid organ transplantion. Our mechanistic analysis indicates a novel role played in the pathogenesis of cGVHD by donor-derived effector memory T cells, particularly TRM, migrating from the graft to recipient blood and then into host tissue. This has potential therapeutic implications for the treatment of cGVHD, particularly in regards to checkpoint inhibition or PD-1 blockade.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Weiner J, Svetlicky N, Schmidt J, Kang J, Sadat M, Karaballa A, Moturi S, Aguirre O, Hawksworth J, Matsumoto C, Fishbein T, Kroemer A. First Report and Mechanistic Analysis of Chronic GVHD after Solid Organ Transplantation [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/first-report-and-mechanistic-analysis-of-chronic-gvhd-after-solid-organ-transplantation/. Accessed April 22, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.